{
  "docId": "019de075-ab2a-73e5-980a-7d480707ba09",
  "docSlug": "340a1966b9939070959283ec1665bfbf",
  "documentTitle": "Kymera | Investor Presentation Deck | 60 slides",
  "authorId": "kymera",
  "authorName": "Kymera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 60,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a Gantt-chart style layout to show the progression of various drug programs.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-ab2a-73e5-980a-7d480707ba09/7",
  "deckHref": "/decks/019de075-ab2a-73e5-980a-7d480707ba09",
  "deckJsonHref": "/decks/019de075-ab2a-73e5-980a-7d480707ba09.json",
  "deckAnchorHref": "/decks/019de075-ab2a-73e5-980a-7d480707ba09#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.85,
        "x": 0.1,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Pipeline progress chart",
      "attrs": null,
      "subkind": "gantt-chart",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dd10f8f9-8e35-4337-a4dc-4e64c069d171",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.5,
        "x": 0.45,
        "y": 0.92
      },
      "kind": "disclaimer",
      "text": "*Option to participate equally in the development and commercialization of Sanofi-partnered programs in the US",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a4f7d236-abcb-4609-905c-0c73f334639e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.25,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "legend",
      "text": "Immunology-Inflammation (orange) and Oncology (dark blue)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "81e90ae8-ae37-43cf-b3ce-c202e31a5daf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.2,
        "y": 0.05
      },
      "kind": "title",
      "text": "Kymera's Pipeline of Novel Protein Degraders",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9ef5354c-37b3-4eb1-a21a-9bd586d4bbc8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Gantt chart",
      "slug": "gantt-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "51065072-b2c4-4bab-acc6-7fcff2e064ce",
      "evidence": "chart/gantt-chart showing pipeline progress",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "e55d1746-3cce-4d0c-9dbc-5d8341c39fb0",
      "evidence": "Visual timeline of drug development programs across stages",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 8,
      "from": 4,
      "beatId": "3ff1231c-28d5-4168-9951-2cb642678691",
      "arcName": "AIDA",
      "arcSlug": "aida",
      "beatName": "Interest",
      "beatSlug": "aida-interest",
      "evidence": "The traction and solution slides build interest in Kymera's technology and pipeline",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 8,
      "from": 4,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "f0707415-95aa-42c7-886c-374c15b46870",
      "evidence": "The deck opens a loop on Kymera's approach and closes it with a clear explanation",
      "position": 0,
      "objective": "What is Kymera's approach to TPD?",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}